Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
SL-28 Intestinal Cancer	Second Life Therapeutics	P1/2	CCC (48)
SLC391 Lung Cancer	SignalChem Lifesciences Corporation	P1/2	CCC (48)
SLC391 Non-Small Cell Lung Carcinoma	SignalChem Lifesciences Corporation	P1/2	CCC (48)
Socazolimab Metastatic Melanoma	Lee's Pharmaceutical Limited	P1/2	CCC (48)
Sonala-001 Glioblastoma	SonALAsense, Inc.	P1/2	CCC (48)
Spedox-6 Soft Tissue Sarcoma	University of California, Irvine	P1/2	CCC (48)
sr604 Hemophilia A	Shanghai RAAS Blood Products Co., Ltd.	P1/2	CCC (48)
S<Sup>3.15</Sup>,S<Sup>3.22</Sup>,S<Sup>3.29</Sup>-[(1,3,5-Triazinane-1,3,5-Triyl)Tris(3-Oxopropane-3,1-Diyl)]{N-[5-Oxo-5-({L-Valyl-N<Sup>5</Sup>-Carbamoyl-L-Ornithyl[(4-Aminophenyl)Methoxy]Carbonyl-N-Methyl-L-Valyl-Lvalyl-(3R,4S,5S)-3-Methoxy-5-Methyl-4-(Methylamino)Heptanoyl-(2R,3R)-N-[(1S,2R)-1-Hydroxy-1-Phenylpropan-2-Yl]-3-Methoxy-2-Methyl-3-[(2S)-Pyrrolidin-2-Yl]Propanamide}-N2.1-Yl)Pentanoyl]-?-Alanyldecakis(N-Methylglycyl)-L-Alanyl-N6-Carbamimidoyl-L-Lysyl-L-?-Aspartyl-L-Cysteinyl-(4R)-4-Hydroxy-L-Prolyl-L-Leucyl-L-Valyl-L-Asparaginyl-L-Prolyl-L-Leucyl-L-Cysteinyl-L-Leucyl-L-Histidyl-L-Prolyl-D-?-Aspartyl-L-Tryptophyl-N6-Carbamimidoyl-L-Lysyl-Lcysteinamide} Carcinoma	BicycleTx Limited	P1/2	CCC (48)
S<Sup>3.15</Sup>,S<Sup>3.22</Sup>,S<Sup>3.29</Sup>-[(1,3,5-Triazinane-1,3,5-Triyl)Tris(3-Oxopropane-3,1-Diyl)]{N-[5-Oxo-5-({L-Valyl-N<Sup>5</Sup>-Carbamoyl-L-Ornithyl[(4-Aminophenyl)Methoxy]Carbonyl-N-Methyl-L-Valyl-Lvalyl-(3R,4S,5S)-3-Methoxy-5-Methyl-4-(Methylamino)Heptanoyl-(2R,3R)-N-[(1S,2R)-1-Hydroxy-1-Phenylpropan-2-Yl]-3-Methoxy-2-Methyl-3-[(2S)-Pyrrolidin-2-Yl]Propanamide}-N2.1-Yl)Pentanoyl]-?-Alanyldecakis(N-Methylglycyl)-L-Alanyl-N6-Carbamimidoyl-L-Lysyl-L-?-Aspartyl-L-Cysteinyl-(4R)-4-Hydroxy-L-Prolyl-L-Leucyl-L-Valyl-L-Asparaginyl-L-Prolyl-L-Leucyl-L-Cysteinyl-L-Leucyl-L-Histidyl-L-Prolyl-D-?-Aspartyl-L-Tryptophyl-N6-Carbamimidoyl-L-Lysyl-Lcysteinamide} Gastric Cancer	BicycleTx Limited	P1/2	CCC (48)
st-1898 tablets Metastatic Melanoma	Beijing Scitech-Mq Pharmaceuticals Limited	P1/2	CCC (48)
Star0602 Epstein-Barr Virus Infection	Marengo Therapeutics, Inc.	P1/2	CCC (48)
Star0602 Female Reproductive System Neoplasm	Marengo Therapeutics, Inc.	P1/2	CCC (48)
Star0602 Breast Cancer	Marengo Therapeutics, Inc.	P1/2	CCC (48)
Star0602 Human Papilloma Virus Infection	Marengo Therapeutics, Inc.	P1/2	CCC (48)
Star0602 Triple-Negative Breast Carcinoma	Marengo Therapeutics, Inc.	P1/2	CCC (48)
Star0602 Vulvar Disease	Marengo Therapeutics, Inc.	P1/2	CCC (48)
Star0602 Vulvar Neoplasm	Marengo Therapeutics, Inc.	P1/2	CCC (48)
Stc-1010 Colorectal Cancer	Brenus Pharma	P1/2	CCC (48)
Stenoparib Cancer	Allarity Therapeutics	P1/2	CCC (48)
Stenoparib Small Cell Lung Carcinoma	VA Office of Research and Development	P1/2	CCC (48)
Sumarotene Prostate Cancer	CuraCell TX AB	P1/2	CCC (48)
Supplementation Of ͢-Sitosterol Subarachnoid Hemorrhage	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1/2	CCC (48)
Surovatamig B-Cell Acute Lymphoblastic Leukemia	AstraZeneca	P1/2	CCC (48)
Surovatamig Mantle Cell Lymphoma	AstraZeneca	P1/2	CCC (48)
Surufatinib Ewing Sarcoma	Hutchmed	P1/2	CCC (48)

Showing 1826 to 1850 of 6,308 assets

PreviousPage 74 of 253Next